Silence Therapeutics (SLN) Insider Trades, Congress & Funds

Smart money at a glance

Filings to Nov 14, 2026

No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersForm 4, 90 days: $0
CongressSTOCK Act, 180 days: None
Big funds13F, quarter ended Sep 30, 2026: 1 added, 0 cut
Federal contractsUSAspending.gov, 12 months: No awards

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

Unlock the full results

Questions about SLN filings

Are insiders buying or selling Silence Therapeutics PLC (SLN) stock?

Neither. Silence Therapeutics PLC (SLN) insiders filed no open-market purchases or sales in the 90 days to Nov 14, 2026, according to SEC Form 4 filings.

Which members of Congress have traded SLN recently?

None. No member of Congress disclosed a SLN trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this SLN smart-money data?

This summary uses filings available on Nov 14, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

FMFmrQ3 2026 13FAdded

13F: filed up to 45 days late.

Smart money on SLN

Lean long1 source:
- Funds

Top traders
No tracked positions at the last update
Insiders
No recent insider filings found
Congress
No recent politician filings found
Funds
- FMR LLC, added, holdings at Sep 30
Lean long · thin1 added · 0 trimmed
Quarter-end 13F holdings changes, not live trades. A trim is not a short.
Influencers
No recent posts found

Each bar is 100% of that source’s money. The notch marks an even split.

Lean is the direction of the latest moves. Descriptive, not advice.

Questions about SLN filings

Are insiders buying or selling Silence Therapeutics PLC (SLN) stock?

Neither. Silence Therapeutics PLC (SLN) insiders filed no open-market purchases or sales in the 90 days to Nov 14, 2026, according to SEC Form 4 filings.

Which members of Congress have traded SLN recently?

None. No member of Congress disclosed a SLN trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this SLN smart-money data?

Funds

What funds are doing

1 move · 6 mo

Buys/Adds$51.5M

Buys/Adds (1)

FM
FMR LLC
Q3 2026 13F
$51.5M
bought
Signals like this: n=3228, 54% finished lower at D15, median -0.8% vs SPY -0.4%

Other smart money signals

Activist stakes, short interest & more

3 items

FM
FMR LLCModerate
FMR LLC filed SC 13G on Silence Therapeutics plc (passive 7.10% stake)
F1
Filing 13d GLight
Tetragon Financial Management LP filed SC 13G/A on Silence Therapeutics plc (passive 5.30% stake)
F1
Filing 13d GLight
Tetragon Financial Management LP filed SC 13G on Silence Therapeutics plc (passive 5.20% stake)

Unlock everything for $29/month

Unlock for $29/month

Reported Nov 12, 2026

Earnings came in 7.7% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Nov 12, 2026

Period ending

Sep 30, 2026

Earnings per share

-$0.24+7.69% beat

-$0.26 expected

Revenue

$0.00

SEC filing

Next report

What the street expects next

Estimates as of Nov 13, 2026

EPS expected

-$0.10

-$0.10 to -$0.10

Revenue expected

$4.5K

6 analysts

Last 30 days

0up1down

Analysts cutting estimates

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Sep 30, 2026Reported Nov 12, 2026	-$0.24est. -$0.26	+7.69%beat	$0.00SEC filing	-100.0%from $159.0K
Jun 30, 2026Reported Aug 10, 2026	-$0.26est. -$0.32	+18.75%beat	$0.00SEC filing	-100.0%from $224.0K
Mar 31, 2026Reported May 7, 2026	-$0.33est. -$0.23	-44.36%miss	$422.0KSEC filing	+197.2%from $142.0K
Dec 31, 2025Reported Mar 5, 2026	-$0.27est. -$0.49	+44.90%beat	GBP 34.0KAlpha Vantage	-99.9%from GBP 24.3M
Sep 30, 2025Reported Nov 6, 2025	-$0.15est. -$0.21	+28.57%beat	$159.0KSEC filing	-89.4%from $1.5M
Jun 30, 2025Reported Aug 7, 2025	-$0.54est. -$0.27	-100.00%miss	$224.0KSEC filing	-70.4%from $756.0K
Mar 31, 2025Reported May 8, 2025	-$0.60est. -$0.41	-46.34%miss	$142.0KSEC filing	-99.1%from $15.7M
Dec 31, 2024Reported Feb 27, 2025	$0.17est. -$0.25	+$0.42beat	GBP 24.3MAlpha Vantage	+1059.0%from GBP 2.1M

Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.

Open: $19.76
High: $19.82
Low: $19.76
Prev close: $19.77
52-wk high: $19.86
52-wk low: $4.19
Mkt cap: $1.23B
ROE: -90.4%
Beta: 1.34
P/S: 2002.6x
P/B: 32.0x
Profit margin: +0.0%
Op margin: -10476.0%

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $1.2B

Valuation

P/S2002.63
P/B31.97

Quality

Operating margin-10476.0%
ROE-90.4%
ROA-29.6%

Growth

Beta1.34

Technicals

Price structure

This stock is in a strong uptrend.

Trend

Strong uptrend

100 / 100

RSI 14

61balanced

20D volatility

291%annualized

52-week range

$19.80

$4.19$19.86

20D support

$8.66recent floor

20D resistance

$19.86recent ceiling

Returns

5D +0.4%20D +111.8%60D +45.5%

Price vs moving averages

SMA20 +3.2%SMA50 +35.9%SMA200 +104.1%

Volume pace

5.24xvs prior 20D

12 macro signals shaping SLN right now

Unlock sector rotation, regime shifts, and macro event windows tied to this stock.

Unlock the full results

Quarter / reported

Earnings per share

Beat or miss

Revenue / income

Revenue vs last year

Sep 30, 2026Nov 12, 2026

-$0.24est. -$0.26

+7.69%

$0.00SEC filing

-100.0%from $159.0K

Jun 30, 2026Aug 10, 2026

-$0.26est. -$0.32

+18.75%

$0.00SEC filing

-100.0%from $224.0K

Mar 31, 2026May 7, 2026

-$0.33est. -$0.23

-44.36%

$422.0KSEC filing

+197.2%from $142.0K

Dec 31, 2025Mar 5, 2026

-$0.27est. -$0.49

+44.90%

GBP 34.0KAlpha Vantage

-99.9%from GBP 24.3M

Sep 30, 2025Nov 6, 2025

-$0.15est. -$0.21

+28.57%

$159.0KSEC filing

-89.4%from $1.5M

Jun 30, 2025Aug 7, 2025

-$0.54est. -$0.27

-100.00%

$224.0KSEC filing

-70.4%from $756.0K

Mar 31, 2025May 8, 2025

-$0.60est. -$0.41

-46.34%

$142.0KSEC filing

-99.1%from $15.7M

Dec 31, 2024Feb 27, 2025

$0.17est. -$0.25

+$0.42

GBP 24.3MAlpha Vantage

+1059.0%from GBP 2.1M

Silence Therapeutics PLC

Smart money at a glance

What do analysts expect?

Questions about SLN filings

Smart money on SLN

Questions about SLN filings

What funds are doing

How top traders are positioned

Activist stakes, short interest & more

Unlock everything for $29/month

Earnings came in 7.7% above what analysts expected.

What the street expects next

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Silence Therapeutics PLC

Smart money at a glance

What do analysts expect?

Questions about SLN filings

Smart money on SLN

Questions about SLN filings

What funds are doing

How top traders are positioned

Activist stakes, short interest & more

Unlock everything for $29/month

Earnings came in 7.7% above what analysts expected.

What the street expects next

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Silence Therapeutics PLC

Overview

Questions about SLN filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Macro

Ask it in Claude or ChatGPT.

Silence Therapeutics PLC

Overview

Questions about SLN filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Macro

Ask it in Claude or ChatGPT.